Waverly Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,891
| Closed | -$229K | – | 225 |
|
|
2017
Q1 | $229K | Buy |
+1,891
| New | +$229K | 0.06% | 191 |
|
|
2015
Q4 | – | Sell |
-65
| Closed | -$10K | – | 418 |
|
|
2015
Q3 | $10K | Sell |
65
-1
| -2% | -$154 | 0.01% | 348 |
|
|
2015
Q2 | $12K | Buy |
+66
| New | +$12K | 0.01% | 260 |
|
|
2014
Q4 | – | Sell |
-612
| Closed | -$101K | – | 714 |
|
|
2014
Q3 | $101K | Hold |
612
| – | – | 0.05% | 137 |
|
|
2014
Q2 | $96K | Buy |
612
+11
| +2% | +$1.73K | 0.04% | 154 |
|
|
2014
Q1 | $91K | Buy |
601
+59
| +11% | +$8.93K | 0.04% | 156 |
|
|
2013
Q4 | $72K | Buy |
+542
| New | +$72K | 0.03% | 281 |
|